Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ferritin heavy chain 1 pseudogene 19 (FTH1P19) is a processed pseudogene present in the human genome. It arises through retro-transposition from FTH1 mRNA but does not encode a functional protein product[2][4]. Like other ferritin pseudogenes, FTH1P19 may participate in gene regulatory networks at the RNA level, such as miRNA competition, but there is no evidence to support a direct protein function or disease role. Its annotation is correct, but it does not fulfill the criteria for a molecular therapeutic target. It is mostly referenced in comparative genomics, studies of gene family evolution, and investigation into non-coding RNA regulatory mechanisms in the human genome[2][4].
None. No mechanisms of action for drugs, as it is not targeted therapeutically.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferritin heavy chain 1 pseudogene 19 (FTH1P19).